In Vitro Antiviral Activity and Single-Dose Pharmacokinetics in Humans of a Novel, Orally Bioavailable Inhibitor of Human Rhinovirus 3C Protease

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.49.6.2267-2275.2005
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

In Vitro Antiviral Activity of AG7088, a Potent Inhibitor of Human Rhinovirus 3C Protease

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1999English

Novel Triterpene Sulfates From Fusarium Compactum Using a Rhinovirus 3C Protease Inhibitor Screen.

Journal of Antibiotics
Drug DiscoveryPharmacology
1996English

Activity of the Human Rhinovirus 3C Protease Studied in Various Buffers, Additives and Detergents Solutions for Recombinant Protein Production

PLoS ONE
Multidisciplinary
2016English

Human Rhinovirus 3C Protease Cleaves RIPK1, Concurrent With Caspase 8 Activation

Scientific Reports
Multidisciplinary
2018English

Citrinin Hydrate and Radicinin: Human Rhinovirus 3c-Protease Inhibitors Discovered in a Target-Directed Microbial Screen.

Journal of Antibiotics
Drug DiscoveryPharmacology
1994English

Single- And Multiple-Dose Pharmacokinetics of Fleroxacin, a Trifluorinated Quinolone, in Humans.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1987English

Single-Dose Pharmacokinetics of Amprenavir, a Human Immunodeficiency Virus Type 1 Protease Inhibitor, in Subjects With Normal or Impaired Hepatic Function

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2000English

Single-Dose Safety, Tolerability, and Pharmacokinetics of the Antibiotic GSK1322322, a Novel Peptide Deformylase Inhibitor

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
2013English

Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy

European Journal of Medicinal Chemistry
MedicineOrganic ChemistryDrug DiscoveryPharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy